Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
Dupixent Sanofi-Aventis Australia Pty Ltd
Product name
Dupixent
Sponsor
Accepted date
Jun-2024
Active ingredients
dupilumab
Proposed indication
For the treatment of uncontrolled chronic obstructive pulmonary disease (COPD) associated with type 2 inflammation.
Application type
C (new indication)
Publication date
Jun-2024
Priority review
Involves faster TGA evaluation of vital and life-saving medicines for which a complete data dossier is available.